# CarePoint Phase 3 Roadmap - QA, UAT, and Production Readiness

## Phase status

Phase 3 is open and focused on end-to-end product validation before pilot, staging signoff, or production go-live.

Closed prerequisites:

- Option B Python Progressive Implementation: closed at V64.
- Design Refinement and UX Stabilization: closed at UX-V6.

## Delivery sequence

| Delivery | Focus | Status |
| --- | --- | --- |
| QA-V1 | Master QA plan and critical E2E test matrix | Complete |
| QA-V2 | Admin functional QA and configuration validation | Complete |
| QA-V3 | Provider functional QA and clinical workflow validation | Complete |
| QA-V4 | Node/API/Python worker E2E validation | Complete |
| QA-V5 | UAT package and acceptance by role | Complete |
| QA-V6 | Production readiness and go-live checklist | Complete |
| QA-V7 | Final QA/UAT closure certificate | Next |

## Current QA-V6 position

QA-V6 prepares production readiness and go-live validation. It consolidates environment, build, migration, backup, rollback, security smoke, observability, UAT signoff consumption, defect gates, and go/no-go evidence.

It does not change backend contracts, Python worker logic, database structure, or application runtime behavior.

## Next delivery

QA-V7 should close the QA/UAT phase with a final certificate:

- QA-V1 through QA-V6 evidence summary.
- Final readiness status.
- Accepted deferrals and post-go-live backlog.
- Final QA/UAT closure certificate.
- Recommendation to proceed to pilot, staging signoff, or production go-live.


## QA-V7 - Final QA/UAT closure certificate

Status: Complete.

Purpose: Close the QA/UAT and production-readiness phase by consolidating QA-V1 through QA-V6 evidence, final role acceptance gates, production readiness references, defect closure rules, final evidence index, and post-close backlog separation.

Recommended next phase: Controlled pilot, staging signoff, or production go-live execution. Do not continue the QA phase unless a closure defect requires a corrective QA-V8.
